NCT07363122Not yet recruiting
Platelet Changes in Type 2 Diabetes
Platelet Indices Changes in Type 2 Diabetes Mellitus and Their Relationship With Inflammatory Markers
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
This study examines changes in platelet indices in people with type 2 diabetes compared to healthy people. It checks if these changes relate to inflammation markers (like hs-CRP) and blood sugar control. Participants get routine blood tests during one clinic visit at Assiut University Hospitals. No treatments or extra procedures are involved.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 15 Jan 2026
- Start date
- Feb 2026
- Primary completion date
- Feb 2027
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07363122
What you commit to
- Study type: Observational
- Planned participants: 200
- From Feb 2026 to the primary completion date, Feb 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent major surgery or trauma (within 3 months)
Other illness
- Type 1 Diabetes Mellitus
- Acute infection, chronic inflammatory disease
- Malignancy.
- Chronic liver, renal, or hematologic disease
Lab values
- Current use of anti-platelet or anti-inflammatory medications
Who the study is looking for
- Adults aged 30-70 years.
- Diagnosed T2DM for at least 1 year.
- Fasting blood glucose ≥126 mg/dL and/or HbA1c ≥ 6.5%
Age in the registry: 30 years to 70 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.